Literature DB >> 5476657

Alterations in enzyme activity in tumors and the implications for chemotherapy.

G A LePage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5476657     DOI： 10.1016/0065-2571(70)90027-0

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  6 in total

1.  Selective inhibition of nuclear DNA synthesis by 9- -D-arabinofuranosyl adenine in rat cells transformed by Rous sarcoma virus.

Authors:  C Shipman; S H Smith; J C Drach
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

2.  Synthesis, physicochemical properties, and cytotoxicity of a series of 5'-ester prodrugs of 5-iodo-2'-deoxyuridine.

Authors:  M M Narurkar; A K Mitra
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

3.  Phase I clinical trial of fludarabine phosphate (F-ara-AMP).

Authors:  E S Casper; A Mittelman; D Kelson; C W Young
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Thermal inactivation as a means of inhibiting the serum-associated deamination of 9-beta-D Arabinofuranosyladenine in tissue culture media.

Authors:  P M Schwartz; C Shipman; R H Carlson; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

5.  Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.

Authors:  P M Schwartz; C Shipman; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

Review 6.  Evolution of the arabinosides and the pharmacology of fludarabine.

Authors:  W Plunkett; V Gandhi
Journal:  Drugs       Date:  1994       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.